Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty

NCT: NCT06991231 · RECRUITING

NCT IDNCT06991231
StatusRECRUITING
Start Date2025-06-13
Completion2027-01-01

Brief Summary

The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that will involve a 1:1 randomization to total knee arthroplasty +/- cryoablation.

Frequently Asked Questions

What is The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty?

The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty is a clinical trial registered under NCT06991231. Current status: RECRUITING.

What is the status of NCT06991231?

The current status of NCT06991231 (The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty) is: RECRUITING.

When did The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty start?

The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty started on 2025-06-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑